DOI: 10.1016/j.ahj.2024.06.004

Paper Summary:

Title: PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study

Author(s): Wu, Zhi-Ming (author);Kan, Jing (author);Ye, Fei (author);You, Wei (author);Wu, Xiang-Qi (author);Tian, Nai-Liang (author);Lin, Song (author);Ge, Zhen (author);Liu, Zhi-Zhong (author);Li, Xiao-Bo (author);Gao, Xiao-Fei (author);Chen, Jing (author);Wang, Yan (author);Wen, Shang-Yu (author);Xie, Ping (author);Cong, Hong-Liang (author);Liu, Li-Jun (author);Zeng, He-Song (author);Zhou, Lei (author);Liu, Fan (author);Zheng, Yong-Hong (author);Li, Rui (author);Ji, Hong-Lei (author);Zhou, Sheng-Hua (author);Zhao, Shou-Ming (author);Qian, Xue-Song (author);Luo, Jun (author);Wang, Xin (author);Zhang, Jun-Jie (author);Chen, Shao-Liang (author)

Year: 2024

DOI: 10.1016/j.ahj.2024.06.004

URL: https://doi.org/10.1016/j.ahj.2024.06.004

Download Paper from Sci-Hub:

Generate Citation

✍: FYIcenter.com

2024-09-12, ∼639👍, 0💬